(Q36892489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Gerald Watts

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Gerard T Chew

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

Diabetes and Vascular Disease Research

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

89-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17654442%20AND%20SRC:MED&resulttype=core&format=json

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The union of vascular and metabolic actions of insulin in sickness and in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The clinical implications of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Endothelial dysfunction: a comprehensive appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Measuring forearm blood flow and interpreting the responses to drugs and mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

von Willebrand factor and development of diabetic nephropathy in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Features of endothelial dysfunction in early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Circulating adhesion molecules in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Clinical utility of endothelial function testing: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Prognostic value of endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Prognostic value of coronary vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Endothelial dysfunction, inflammation and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Is the fatty meal a trigger for acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Postprandial glucose and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Beneficial cardiovascular pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effect of exercise training on endothelium-derived nitric oxide function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular effects of wine polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular complications in diabetes mellitus: the role of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Insulin therapy improves endothelial function in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of glibenclamide on blood pressure and cardiovascular responsiveness in non-insulin dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Repaglinide administration improves brachial reactivity in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Improved endothelial function with metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Lipids and the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

How high-density lipoprotein protects against the effects of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Endothelial protection by high-density lipoproteins: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Improvement in endothelial dysfunction with LDL cholesterol level < 80 mg/dl in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Acute effects of monounsaturated fatty acids with and without omega-3 fatty acids on vascular reactivity in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

The renin-angiotensin-aldosterone system, glucose metabolism and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Angiotensin II and nitric oxide interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid-lowering therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effect of estrogen on endothelial function and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular effects of estrogen in type II diabetic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Effect of lowering tumour necrosis factor-alpha on vascular endothelial function in Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2007.026